feed,title,long_url,short_url
Benzinga,These Analysts Revise Their Forecasts On Workday After Q4 Results,https://benzinga.com/news/earnings/24/02/37343053/these-analysts-revise-their-forecasts-on-workday-after-q4-results,https://da.gd/TcVIU
Benzinga,"Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data",https://benzinga.com/general/biotech/24/02/37342986/regulatory-setback-for-minerva-neurosciences-schizophrenia-treatment-candidate-fda-asks-for-more-,https://da.gd/zqfdV7
